TARSUS PHARMACEUTICALS, INC.: cashflow_investing
| Value | {"amount": -42115000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-12-31 |
| Status | current |
| Entity | TARSUS PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:18:26.464024+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/51c870d3-6d0c-486e-9a70-217e315a2f22
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001819790-26-000019Retrieved: 2026-08-19T18:18:26.464024+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001819790/cashflow-investing/2025-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/51c870d3-6d0c-486e-9a70-217e315a2f22
History
- no predecessors — first report